Similar Articles
141 Low level of hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in compensated cirrhotic patients
142 Systemic treatment of hepatocellular carcinoma secondary to non-alcoholic fatty liver disease
143 Lenvatinib, sintilimab combined interventional treatment vs bevacizumab, sintilimab combined interventional treatment for intermediate-advanced unresectable hepatocellular carcinoma
144 Pathologic complete response to conversion therapy in hepatocellular carcinoma using patient-derived organoids: A case report
145 From biomarker discovery to combined therapies: Advancing hepatocellular carcinoma treatment strategies
146 MicroRNA-206 as a promising epigenetic approach to modulate tumor-associated macrophages in hepatocellular carcinoma
147 Yttrium-90 radioembolization treatment strategies for management of hepatocellular carcinoma
148 Single incision laparoscopic surgery for hepatocellular carcinoma
149 Urgent need for prognostic markers for hepatocellular carcinoma in the light of genomic instability and non-coding RNA signatures
150 Reassessment of palliative surgery in conversion therapy of previously unresectable hepatocellular carcinoma: Two case reports and review of literature
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA